Skip to main content
Coreo AG logo

Coreo AG — Investor Relations & Filings

Ticker · CORE ISIN · DE000A40KYB8 LEI · 391200FQ2JQTU4IUY679 F Real estate activities
Open in API
Filings indexed 417 across all filing types
Latest filing 2007-03-07 Regulatory Filings
Country DE Germany
Listing F CORE

About Coreo AG

https://coreo.de/en/

Coreo AG is a real estate investment company focused on the acquisition, development, and management of residential and commercial properties. The company's strategy centers on value-add opportunities, targeting properties with significant potential for appreciation. Coreo AG employs an active 'manage to core' approach to sustainably increase the value of its assets, with the goal of building and expanding an efficiently managed, high-yield real estate portfolio. Investment focus is primarily on residential properties, preferably in medium-sized centers, with individual investment volumes typically ranging from 5 to 20 million euros. The company's portfolio comprises a mix of residential, commercial, and combined-use properties.

Recent filings

Filing Released Lang Actions
Nanostart AG: Nanostart-Beteiligung Nanosys kooperiert mit Rockwell Collins
Regulatory Filings Classification · 100% confidence The document is a press release from Nanostart AG, dated March 7, 2007, announcing a cooperation agreement between its portfolio company, Nanosys Inc., and Rockwell Collins Display Systems. It details a business partnership regarding technology integration. This type of announcement, which reports on a specific business development (a partnership/deal) rather than routine financial results (ER, IR, 10-K) or mandatory regulatory filings, fits best under the general category for corporate news that isn't covered by more specific codes like DIRS, DIV, or CAP. Since it is a general corporate announcement about a business event, and not a formal regulatory filing like a 10-K or a specific shareholder/insider event, the most appropriate classification among the provided options is 'Regulatory Filings' (RNS) as a catch-all for significant, non-standard corporate news releases, or potentially 'LTR' if it were a legal matter, but here it is a business development. Given the options, RNS serves as the best fit for a general corporate news release about a partnership, especially since there is no specific code for 'Business Development Announcement'. However, upon reviewing the definitions, RNS is defined as 'General regulatory announcements and fallback category for miscellaneous filings'. This is a specific corporate announcement, not a general regulatory filing. Since there is no specific code for 'Partnership Announcement' or 'Business News', and it is not a financial report, management change, or insider trade, RNS is the designated fallback. The document length (5225 chars) is substantial enough that it is the report itself, not just an announcement of a report (RPA).
2007-03-07 German
Regulatory Filings 2007
Regulatory Filings
2007-01-31 German
Nanostart-Beteiligung Nanosys kooperiert mit NTT DoCoMo bei nanotechnologischen Anwendungen im Bereich Wireless Communication
M&A Activity Classification · 99% confidence The document is a 'Corporate News' release dated January 12, 2007, announcing a collaboration agreement and investment between Nanostart's holding Nanosys, NTT DoCoMo, and DoCoMo Capital regarding nanotechnology for wireless communication. This type of announcement, detailing strategic partnerships, investments, and business developments, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, SHA, DIRS). It is a general corporate update distributed via a news service (DGAP). Since it is not a formal regulatory filing like a 10-K or a specific report like an AR or CT, and it details corporate strategy/partnership, the most appropriate general category is 'Regulatory Filings' (RNS) as a catch-all for significant, non-standard corporate news releases, although 'LTR' (Legal Proceedings Report) or 'TAR' (M&A Activity) are not applicable as this is a collaboration/investment, not a takeover or lawsuit. Given the options, RNS serves as the best fit for a general, non-standard corporate news announcement.
2007-01-12 German
Nanostart AG: Nanostart-Beteiligung MagForce Nanotechnologies startet Wirksamkeitsstudie (Phase II) fur Patienten mit Prostatakarzinom
Regulatory Filings Classification · 100% confidence The document is a 'Corporate News' announcement dated January 11, 2007, released via DGAP. It details a clinical trial start (Phase II study for prostate cancer treatment) by MagForce Nanotechnologies AG, in which Nanostart AG has a stake. This is not a formal regulatory filing like a 10-K or IR, nor is it a transcript (CT) or a formal dividend/share change notice. It is an announcement about operational/clinical progress, which fits best under the general category of corporate news that doesn't fit a more specific financial report type. Since it is a general corporate update/news release that doesn't fit the specific definitions (like ER, CAP, DIV, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which often serves as a catch-all for significant, non-standardized corporate announcements distributed via official channels like DGAP.
2007-01-11 German
Nanostart AG: Transparenzmeldung gema 17 Absatz 2 AGB fur den Freiverkehr an der Frankfurter Wertpapierborse
Major Shareholding Notification Classification · 99% confidence The document is a short corporate news release dated January 4, 2007, announcing that Nanostart AG has sold its stakes in two publicly traded holdings (NanoFocus AG and Obducat AB) for 6.9 million Euros. This transaction involves the disposal of investments and the realization of capital gains, which directly relates to the company's capital structure and financing activities (selling assets to reinvest). While it is a corporate announcement, the core subject is the successful divestment of equity holdings and the resulting capital realization. This fits best under 'Capital/Financing Update' (CAP) as it details a significant change in the company's asset base and investment strategy, rather than being a general regulatory filing (RNS) or a management change (MANG). It is not a formal financial report (10-K, IR) or an earnings release (ER).
2007-01-04 German
Nanostart AG erhoht ihre Beteiligung an der Lumiphore, Inc.
M&A Activity Classification · 99% confidence The document is a 'Corporate News' release dated December 15, 2006, announcing that Nanostart AG increased its stake in Lumiphore, Inc., becoming the lead investor and largest shareholder (17.3%). It details the investment, management changes (a Nanostart board seat), and the strategic importance of the investment in the US market. This type of announcement, detailing financing activities, capital structure changes (increasing a stake), and strategic corporate moves, aligns best with the 'Capital/Financing Update' category. It is not an Annual Report (10-K), an Earnings Release (ER), or a Call Transcript (CT). Since it is a specific announcement about an investment/financing activity, 'CAP' is the most precise fit over the general 'RNS' fallback.
2006-12-15 German

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.